| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2008
|
9.17
|
|
2
|
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.
|
Clin Infect Dis
|
2002
|
6.99
|
|
3
|
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.
|
J Acquir Immune Defic Syndr
|
2004
|
5.94
|
|
4
|
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.
|
Sci Transl Med
|
2011
|
5.21
|
|
5
|
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
|
N Engl J Med
|
2004
|
5.04
|
|
6
|
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
|
J Infect Dis
|
2007
|
4.52
|
|
7
|
Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.
|
JAMA
|
2003
|
4.38
|
|
8
|
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
|
Lancet
|
2010
|
4.23
|
|
9
|
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.
|
J Infect Dis
|
2008
|
4.05
|
|
10
|
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.
|
Nat Med
|
2009
|
4.03
|
|
11
|
Genital herpes.
|
Lancet
|
2007
|
3.83
|
|
12
|
Frequent and prolonged shedding of bocavirus in young children attending daycare.
|
J Infect Dis
|
2010
|
3.67
|
|
13
|
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
|
PLoS One
|
2009
|
3.66
|
|
14
|
Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.
|
J Exp Med
|
2007
|
3.66
|
|
15
|
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.
|
AIDS
|
2011
|
3.61
|
|
16
|
Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
|
J Infect Dis
|
2004
|
3.23
|
|
17
|
A population-based study of primary human herpesvirus 6 infection.
|
N Engl J Med
|
2005
|
3.07
|
|
18
|
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples.
|
J Infect Dis
|
2012
|
3.06
|
|
19
|
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.
|
PLoS One
|
2008
|
3.05
|
|
20
|
Risk factors for herpes simplex virus transmission to pregnant women: a couples study.
|
Am J Obstet Gynecol
|
2005
|
2.89
|
|
21
|
Maternal and neonatal herpes simplex virus infections.
|
N Engl J Med
|
2009
|
2.85
|
|
22
|
Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.
|
J Clin Microbiol
|
2002
|
2.83
|
|
23
|
Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.
|
J Infect Dis
|
2008
|
2.77
|
|
24
|
Efficacy results of a trial of a herpes simplex vaccine.
|
N Engl J Med
|
2012
|
2.77
|
|
25
|
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
|
Clin Infect Dis
|
2012
|
2.55
|
|
26
|
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
|
Lancet
|
2012
|
2.54
|
|
27
|
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.
|
PLoS One
|
2010
|
2.48
|
|
28
|
Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.
|
J Infect Dis
|
2010
|
2.45
|
|
29
|
Genital herpes complicating pregnancy.
|
Obstet Gynecol
|
2005
|
2.45
|
|
30
|
Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
|
Clin Infect Dis
|
2006
|
2.43
|
|
31
|
Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa.
|
J Clin Microbiol
|
2007
|
2.42
|
|
32
|
Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
|
Blood
|
2003
|
2.41
|
|
33
|
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.
|
Nature
|
2013
|
2.38
|
|
34
|
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
|
Pediatr Blood Cancer
|
2010
|
2.37
|
|
35
|
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
|
PLoS One
|
2011
|
2.36
|
|
36
|
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe.
|
AIDS
|
2007
|
2.35
|
|
37
|
Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection.
|
J Infect Dis
|
2007
|
2.33
|
|
38
|
Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.
|
J Infect Dis
|
2008
|
2.31
|
|
39
|
The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study*.
|
Crit Care Med
|
2012
|
2.29
|
|
40
|
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.
|
J Infect Dis
|
2008
|
2.27
|
|
41
|
Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
|
J Infect Dis
|
2007
|
2.16
|
|
42
|
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
|
Clin Infect Dis
|
2011
|
2.15
|
|
43
|
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.
|
J Acquir Immune Defic Syndr
|
2010
|
2.01
|
|
44
|
Genital herpes and human immunodeficiency virus: double trouble.
|
Bull World Health Organ
|
2004
|
1.95
|
|
45
|
Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.
|
Sex Transm Dis
|
2003
|
1.92
|
|
46
|
Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic.
|
Sex Transm Dis
|
2005
|
1.91
|
|
47
|
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.
|
JAMA
|
2011
|
1.85
|
|
48
|
Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay.
|
J Med Virol
|
2005
|
1.81
|
|
49
|
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.
|
J Infect Dis
|
2012
|
1.80
|
|
50
|
Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.
|
J Clin Invest
|
2002
|
1.79
|
|
51
|
Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
|
J Infect Dis
|
2004
|
1.74
|
|
52
|
Clinical correlates of herpes simplex virus viremia among hospitalized adults.
|
Clin Infect Dis
|
2009
|
1.69
|
|
53
|
Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.
|
J Infect Dis
|
2004
|
1.65
|
|
54
|
Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.
|
J Acquir Immune Defic Syndr
|
2011
|
1.63
|
|
55
|
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
|
J Infect Dis
|
2006
|
1.62
|
|
56
|
Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.
|
Sci Transl Med
|
2009
|
1.60
|
|
57
|
From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.
|
Sex Transm Dis
|
2008
|
1.58
|
|
58
|
A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.
|
Arch Intern Med
|
2009
|
1.56
|
|
59
|
Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children.
|
Influenza Other Respir Viruses
|
2011
|
1.50
|
|
60
|
Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
|
Proc Natl Acad Sci U S A
|
2010
|
1.49
|
|
61
|
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes.
|
Am J Obstet Gynecol
|
2006
|
1.46
|
|
62
|
Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2012
|
1.44
|
|
63
|
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.
|
Blood
|
2007
|
1.43
|
|
64
|
HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
|
AIDS
|
2009
|
1.43
|
|
65
|
Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.
|
Sex Transm Dis
|
2012
|
1.41
|
|
66
|
Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
|
J Acquir Immune Defic Syndr
|
2014
|
1.40
|
|
67
|
Natural history of genital herpes simplex virus type 1 infection.
|
Sex Transm Dis
|
2003
|
1.38
|
|
68
|
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
|
J Infect Dis
|
2007
|
1.37
|
|
69
|
Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.
|
Proc Natl Acad Sci U S A
|
2003
|
1.36
|
|
70
|
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
|
J Infect Dis
|
2010
|
1.36
|
|
71
|
Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.
|
PLoS One
|
2011
|
1.35
|
|
72
|
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
|
AIDS
|
2008
|
1.33
|
|
73
|
Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.
|
Sex Transm Infect
|
2007
|
1.32
|
|
74
|
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.
|
Biol Blood Marrow Transplant
|
2004
|
1.31
|
|
75
|
Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.
|
J Infect Dis
|
2004
|
1.29
|
|
76
|
T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
|
J Immunol
|
2003
|
1.29
|
|
77
|
HSV-2: in pursuit of a vaccine.
|
J Clin Invest
|
2011
|
1.29
|
|
78
|
Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.
|
J Infect Dis
|
2006
|
1.27
|
|
79
|
Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
|
Obstet Gynecol
|
2007
|
1.24
|
|
80
|
HIV infection and human herpesvirus-8 oral shedding among men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2004
|
1.23
|
|
81
|
Herpes simplex virus viremia during primary genital infection.
|
J Infect Dis
|
2008
|
1.20
|
|
82
|
Condom use and the prevention of genital herpes acquisition.
|
Herpes
|
2002
|
1.19
|
|
83
|
The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.
|
J Infect Dis
|
2011
|
1.19
|
|
84
|
How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?
|
J Infect Dis
|
2003
|
1.18
|
|
85
|
Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men.
|
J Infect Dis
|
2002
|
1.18
|
|
86
|
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.
|
J Clin Invest
|
2012
|
1.16
|
|
87
|
Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.
|
J Acquir Immune Defic Syndr
|
2010
|
1.16
|
|
88
|
Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.
|
Clin Vaccine Immunol
|
2008
|
1.12
|
|
89
|
Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
|
J Infect Dis
|
2006
|
1.12
|
|
90
|
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.
|
Elife
|
2013
|
1.12
|
|
91
|
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.
|
PLoS One
|
2009
|
1.11
|
|
92
|
Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
|
PLoS One
|
2010
|
1.11
|
|
93
|
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.
|
AIDS Patient Care STDS
|
2009
|
1.10
|
|
94
|
Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons.
|
J Immunol
|
2010
|
1.10
|
|
95
|
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
|
Vaccine
|
2005
|
1.09
|
|
96
|
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
|
J Infect Dis
|
2010
|
1.09
|
|
97
|
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.
|
Vaccine
|
2012
|
1.09
|
|
98
|
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
|
J Infect Dis
|
2011
|
1.08
|
|
99
|
Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.
|
J Clin Microbiol
|
2006
|
1.07
|
|
100
|
Internet and email use among STD clinic patients.
|
Sex Transm Dis
|
2008
|
1.07
|
|
101
|
Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score.
|
PLoS One
|
2013
|
1.06
|
|
102
|
Evasion of the mucosal innate immune system by herpes simplex virus type 2.
|
J Virol
|
2009
|
1.05
|
|
103
|
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
|
J Infect Dis
|
2011
|
1.05
|
|
104
|
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
|
J Infect Dis
|
2011
|
1.04
|
|
105
|
Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.
|
J Infect Dis
|
2010
|
1.03
|
|
106
|
Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.
|
AIDS Res Hum Retroviruses
|
2013
|
1.02
|
|
107
|
Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
|
Ann Intern Med
|
2010
|
1.01
|
|
108
|
Diagnostics for herpes simplex virus: is PCR the new gold standard?
|
Mol Diagn Ther
|
2006
|
1.01
|
|
109
|
Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
|
J Antimicrob Chemother
|
2011
|
1.01
|
|
110
|
Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.
|
J Clin Immunol
|
2010
|
1.01
|
|
111
|
Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.
|
J Infect Dis
|
2004
|
1.00
|
|
112
|
Detection of bocavirus in saliva of children with and without respiratory illness.
|
J Clin Microbiol
|
2009
|
0.99
|
|
113
|
Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2).
|
J Clin Virol
|
2006
|
0.98
|
|
114
|
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
|
Sex Transm Dis
|
2008
|
0.98
|
|
115
|
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.
|
J Infect Dis
|
2012
|
0.98
|
|
116
|
Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.
|
Antimicrob Agents Chemother
|
2013
|
0.97
|
|
117
|
Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.
|
PLoS One
|
2011
|
0.97
|
|
118
|
Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.
|
J Infect Dis
|
2007
|
0.97
|
|
119
|
Influenza-associated cystic fibrosis pulmonary exacerbations.
|
Chest
|
2009
|
0.97
|
|
120
|
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
|
J Virol
|
2014
|
0.95
|
|
121
|
An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection.
|
J Virol
|
2012
|
0.94
|
|
122
|
Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists.
|
Clin Infect Dis
|
2003
|
0.94
|
|
123
|
Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.
|
Clin Infect Dis
|
2013
|
0.93
|
|
124
|
Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.
|
Clin Vaccine Immunol
|
2008
|
0.93
|
|
125
|
HHV-8 infection: a model for reactivation and transmission.
|
Rev Med Virol
|
2002
|
0.93
|
|
126
|
A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.
|
AIDS Behav
|
2011
|
0.93
|
|
127
|
Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection.
|
J Clin Microbiol
|
2002
|
0.93
|
|
128
|
Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G.
|
Sex Transm Dis
|
2004
|
0.92
|
|
129
|
Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.
|
Sex Transm Dis
|
2003
|
0.92
|
|
130
|
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
|
J Infect Dis
|
2013
|
0.89
|
|
131
|
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
|
J Infect Dis
|
2003
|
0.89
|
|
132
|
ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.
|
J Infect Dis
|
2012
|
0.89
|
|
133
|
Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2008
|
0.89
|
|
134
|
Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.
|
Sex Transm Dis
|
2010
|
0.88
|
|
135
|
Prenatal herpes simplex virus serologic screening beliefs and practices among obstetricians.
|
Obstet Gynecol
|
2007
|
0.88
|
|
136
|
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
|
J Clin Microbiol
|
2010
|
0.88
|
|
137
|
CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.
|
J Virol
|
2012
|
0.87
|
|
138
|
Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
|
Acta Obstet Gynecol Scand
|
2007
|
0.87
|
|
139
|
Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virus.
|
Sex Transm Dis
|
2003
|
0.87
|
|
140
|
Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
|
Expert Opin Pharmacother
|
2006
|
0.86
|
|
141
|
Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains.
|
J Clin Microbiol
|
2006
|
0.85
|
|
142
|
Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.
|
J Med Virol
|
2013
|
0.85
|
|
143
|
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
|
PLoS One
|
2012
|
0.85
|
|
144
|
Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
|
Sex Transm Dis
|
2007
|
0.85
|
|
145
|
Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons.
|
J Med Virol
|
2008
|
0.84
|
|
146
|
Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.
|
Gen Hosp Psychiatry
|
2010
|
0.84
|
|
147
|
Molecular epidemiology of respiratory syncytial virus transmission in childcare.
|
J Clin Virol
|
2013
|
0.84
|
|
148
|
Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial.
|
BMC Infect Dis
|
2012
|
0.84
|
|
149
|
Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women.
|
J Infect Dis
|
2005
|
0.84
|
|
150
|
Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding.
|
J R Soc Interface
|
2014
|
0.84
|
|
151
|
Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.
|
J Virol
|
2012
|
0.83
|
|
152
|
The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.
|
Brain Behav Immun
|
2011
|
0.83
|
|
153
|
HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae.
|
Sex Transm Dis
|
2007
|
0.83
|
|
154
|
Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
|
Sex Transm Dis
|
2008
|
0.83
|
|
155
|
Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
|
J Infect Dis
|
2010
|
0.83
|
|
156
|
Rapid polymerase chain reaction assay to detect herpes simplex virus in the genital tract of women in labor.
|
Obstet Gynecol
|
2010
|
0.83
|
|
157
|
High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
|
J Acquir Immune Defic Syndr
|
2013
|
0.83
|
|
158
|
Targeted prenatal herpes simplex virus testing: can we identify women at risk of transmission to the neonate?
|
Am J Obstet Gynecol
|
2006
|
0.83
|
|
159
|
Type-specific testing for herpes simplex virus.
|
Expert Rev Mol Diagn
|
2004
|
0.83
|
|
160
|
An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.
|
J Clin Virol
|
2013
|
0.83
|
|
161
|
Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review.
|
Sex Transm Infect
|
2011
|
0.83
|
|
162
|
Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.
|
PLoS One
|
2012
|
0.82
|
|
163
|
APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.
|
Sex Transm Infect
|
2010
|
0.82
|
|
164
|
Genital HSV detection among HIV-1-infected pregnant women in labor.
|
Infect Dis Obstet Gynecol
|
2011
|
0.82
|
|
165
|
Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
|
AIDS Res Hum Retroviruses
|
2012
|
0.82
|
|
166
|
The acceptance of HSV-testing partners of HSV-2 seronegative pregnant women.
|
Sex Transm Dis
|
2009
|
0.81
|
|
167
|
Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks.
|
Obstet Gynecol
|
2006
|
0.81
|
|
168
|
Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.
|
PLoS One
|
2012
|
0.81
|
|
169
|
Healthcare seeking and sexual behavior among patients with symptomatic newly acquired genital herpes.
|
Sex Transm Dis
|
2008
|
0.80
|
|
170
|
Poor correlation between genital lesions and detection of herpes simplex virus in women in labor.
|
Obstet Gynecol
|
2005
|
0.80
|
|
171
|
Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
|
J Med Virol
|
2011
|
0.80
|
|
172
|
Human herpesvirus 8 infection among adolescents in the REACH cohort.
|
Arch Pediatr Adolesc Med
|
2006
|
0.80
|
|
173
|
Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.
|
Antimicrob Agents Chemother
|
2012
|
0.80
|
|
174
|
Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2.
|
Vaccine
|
2011
|
0.80
|
|
175
|
Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.
|
Sex Transm Dis
|
2012
|
0.80
|
|
176
|
Herpes Simplex Virus Type 1 Shedding in Tears and Nasal and Oral Mucosa of Healthy Adults.
|
Sex Transm Dis
|
2016
|
0.80
|
|
177
|
Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications.
|
J Infect Dis
|
2003
|
0.79
|
|
178
|
Oral HHV-8 replication among women in Mombasa, Kenya.
|
J Med Virol
|
2014
|
0.77
|
|
179
|
High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.
|
Sex Transm Dis
|
2015
|
0.76
|
|
180
|
A prospective cohort study of partner testing for herpes simplex virus and sexual behavior during pregnancy.
|
J Infect Dis
|
2012
|
0.76
|
|
181
|
Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy.
|
J Obstet Gynaecol Can
|
2009
|
0.75
|
|
182
|
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection.
|
Sex Transm Dis
|
2016
|
0.75
|
|
183
|
Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men.
|
Sex Transm Dis
|
2011
|
0.75
|
|
184
|
Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
|
Sex Transm Dis
|
2017
|
0.75
|
|
185
|
Unusual appendicitis.
|
Clin Infect Dis
|
2003
|
0.75
|
|
186
|
Clinical burden of herpes simplex virus disease in people with human immunodeficiency virus.
|
Sex Transm Dis
|
2012
|
0.75
|
|
187
|
Human Metapneumovirus and Other Respiratory Viral Infections during Pregnancy and Birth, Nepal.
|
Emerg Infect Dis
|
2017
|
0.75
|
|
188
|
Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding.
|
Herpes
|
2006
|
0.75
|
|
189
|
Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
|
Pediatr Infect Dis J
|
2017
|
0.75
|